SEC Stock Data Quick Answer Avalon GloboCare Corp. reported R&D Expense of $109.6 thousand for fiscal year 2023. Avalon GloboCare Corp. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2023 $109.6K -85.0% 2022 $731.3K -28.7% 2021 $1.03M +16.0% 2020 $883.9K -50.4% 2019 $1.78M +4461.8% 2018 $39.1K — Quarterly R&D Expense Quarter Ending R&D Expense YoY … Read more
Quick Answer Avalon GloboCare Corp. reported Stockholders Equity of $9.23 million for fiscal year 2025. Avalon GloboCare Corp. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $9.23M +30.0% 2024 $7.10M -3.6% 2023 $7.37M -34.0% 2022 $11.16M +261.8% 2021 $3.08M -25.1% 2020 $4.12M -7.8% 2019 $4.47M -22.3% 2019 $5.75M -48.9% 2018 $11.25M … Read more
Quick Answer Avalon GloboCare Corp. reported Cash and Equivalents of $285.4 thousand for fiscal year 2023. Avalon GloboCare Corp. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2023 $285.4K -85.7% 2022 $1.99M +146.5% 2021 $807.5K +11.1% 2020 $726.6K -5.0% 2019 $764.9K -66.0% 2018 $2.25M -25.6% 2017 $3.03M +4.9% 2016 $2.89M … Read more
Quick Answer Avalon GloboCare Corp. reported Total Assets of $23.40 million for fiscal year 2025. Avalon GloboCare Corp. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $23.40M +11.5% 2024 $20.99M +2.0% 2023 $20.58M +4.2% 2022 $19.75M +92.8% 2021 $10.24M -1.2% 2020 $10.37M -1.2% 2019 $10.49M -21.7% 2018 $13.40M +5.7% 2017 $12.67M … Read more
Quick Answer Avalon GloboCare Corp. reported Diluted EPS of $5.64 per share (loss) for fiscal year 2025. Avalon GloboCare Corp. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$5.64 +33.2% 2024 -$8.44 +64.5% 2023 -$23.80 -1759.4% 2022 -$1.28 -19.6% 2021 -$1.07 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ … Read more
Quick Answer Avalon GloboCare Corp. reported Net Income of -$18.26 million for fiscal year 2025. Avalon GloboCare Corp. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$18.26M -19433.4% 2025 $94.5K +101.2% 2024 -$7.90M +52.7% 2023 -$16.71M -40.0% 2022 -$11.93M -31.2% 2021 -$9.09M +28.3% 2020 -$12.68M +29.8% 2019 -$18.07M -124.4% 2018 -$8.05M … Read more
Quick Answer Avalon GloboCare Corp. reported Total Revenue of $1.33 million for fiscal year 2024. Avalon GloboCare Corp. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2024 $1.33M +6.2% 2023 $1.26M +4.5% 2022 $1.20M -13.6% 2021 $1.39M +1.0% 2020 $1.38M -10.9% 2019 $1.55M -1.0% 2018 $1.56M +45.0% 2017 $1.08M +74.8% 2016 $616.4K … Read more
Quick Answer Avalon GloboCare Corp. reported Total Revenue of $1.33 million for fiscal year 2024. Avalon GloboCare Corp. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue — $1.33M+6.2% $1.26M+4.5% $1.20M-13.6% $1.39M+1.0% $1.38M-10.9% Net Income $94.5K+101.2% -$7.90M+52.7% -$16.71M-40.0% -$11.93M-31.2% -$9.09M+28.3% -$12.68M+29.8% Diluted EPS -$5.64+33.2% -$8.44+64.5% -$23.80-1759.4% -$1.28-19.6% -$1.07 — Total … Read more
Quick Answer ALBEMARLE CORP reported Shares Outstanding of 117.72 million shares for fiscal year 2025. ALBEMARLE CORP Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 117.72M +0.1% 2024 117.56M +0.2% 2023 117.36M +0.2% 2022 117.17M +0.1% 2021 117.02M +9.5% 2020 106.84M +0.8% 2019 106.04M +0.4% 2018 105.62M -4.5% 2017 110.55M -1.8% … Read more
Quick Answer ALBEMARLE CORP reported Gross Profit of $668.72 million for fiscal year 2025. ALBEMARLE CORP Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $668.72M +969.3% 2024 $62.54M -94.7% 2023 $1.19B -61.4% 2022 $3.07B +208.1% 2021 $997.97M +0.3% 2020 $994.85M -20.9% 2019 $1.26B +3.3% 2018 $1.22B +10.0% 2017 $1.11B +14.0% 2016 … Read more